UMass Chan unveils first lab to monitor AI use in health care simulations masslive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from masslive.com Daily Mail and Mail on Sunday newspapers.
UMass Chan Medical School and UMass Lowell have received an $8.9 million award from the National Institutes of Health (NIH) for renewed support of their initiative to advance the development of home-based and point-of-care health technologies.
Startups to unveil cutting-edge point-of-care technologies at Boston medtech event sciencex.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencex.com Daily Mail and Mail on Sunday newspapers.
Six new products poised to improve the quality of health care will take center stage at a June event for life sciences innovators and investors reshaping the industry.
Serial rapid antigen testing on par with PCR COVID-19 tests, RADx team reports By Susan E.W. Spencer July 07, 2021
A longitudinal study co-authored by UMass Medical School researchers as part of the National Institutes of Health’s Rapid Acceleration of Diagnostics (RADx) initiative reported that PCR testing for SARS-CoV-2 and rapid antigen testing were equally effective in detecting infection when tests were given at least twice per week.
Study results represent good news for widespread prevention programs because antigen tests at the point of care or at home can deliver immediate results and are less costly than lab tests.
While individual PCR tests, considered the gold standard, are more sensitive than antigen tests particularly early in infection, the results showed that both testing approaches can give 98 percent sensitivity when taken regularly as part of a screening program, according to a news release from NIH. That’s good news fo